Zealand Pharma A/S (ZEAL) 2023年CSR报告「NASDAQ」.pdf

1、Our responsibility 30Our business model 32Double Materiality Assessment 34Our patients 35Our people 38Our operations 42Sustainability:Our patients,people and operationsContentsThe big pictureOur businessSustainabilityCorporate governanceFinancial statementsZealand Pharma Annual Report 202329At Zeala

2、nd,we are committed to changing lives with next-generation peptide therapeutics.Through our innovative pipeline,we seek to make a difference for people living with chronic diseases while acknowledging our responsibility to society,our employees,and the environment.Our responsibilityThe Sustainable D

3、evelopment Goals(SDGs)We have adopted and incorporated selected UN Sustainable Development Goals that are aligned with our business impact and connect Zealands efforts with those of other companies to address global challenges.We remain committed to these UN Sustainable Development Goals:SDG 3:Ensur

4、e healthy lives and promote well-being for all at all agesSDG 5:Achieve gender equality and empower all women and girlsSDG 10:Reduce inequality within and among countriesSDG 12:Ensure sustainable consumption and production patternsSDG 16:Promote peaceful and inclusive societies for sustainable devel

5、opment,provide access to justice for all and build effective,accountable and inclusive institutions at all levelsSDG 17:Strengthen the means of implementation and revitalize the global partnership for sustain-able developmentOur patientsOur peopleOur operationsOur focus areasAs we pursue our ambitio

6、n of becoming the worlds best peptide drug discovery and development company,our impact on global health and society continues to increase.We recognize the importance of operating a responsible and sustainable business as we grow and expand our pipeline.In 2023,Zealand further refined the companys E